nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—MUC2—hindbrain—amyotrophic lateral sclerosis	0.0475	0.208	CbGeAlD
Pranlukast—MUC2—embryo—amyotrophic lateral sclerosis	0.0297	0.13	CbGeAlD
Pranlukast—MUC2—brainstem—amyotrophic lateral sclerosis	0.0272	0.119	CbGeAlD
Pranlukast—MUC2—spinal cord—amyotrophic lateral sclerosis	0.0169	0.0741	CbGeAlD
Pranlukast—MUC2—nervous system—amyotrophic lateral sclerosis	0.0143	0.0624	CbGeAlD
Pranlukast—MUC2—central nervous system—amyotrophic lateral sclerosis	0.0137	0.0601	CbGeAlD
Pranlukast—MUC2—cerebellum—amyotrophic lateral sclerosis	0.0134	0.0587	CbGeAlD
Pranlukast—MUC2—brain—amyotrophic lateral sclerosis	0.0109	0.0477	CbGeAlD
Pranlukast—NFKB1—nervous system—amyotrophic lateral sclerosis	0.00813	0.0356	CbGeAlD
Pranlukast—CYSLTR1—nervous system—amyotrophic lateral sclerosis	0.00799	0.035	CbGeAlD
Pranlukast—NFKB1—central nervous system—amyotrophic lateral sclerosis	0.00783	0.0343	CbGeAlD
Pranlukast—CYSLTR1—central nervous system—amyotrophic lateral sclerosis	0.00769	0.0337	CbGeAlD
Pranlukast—NFKB1—cerebellum—amyotrophic lateral sclerosis	0.00765	0.0335	CbGeAlD
Pranlukast—NFKB1—brain—amyotrophic lateral sclerosis	0.00621	0.0272	CbGeAlD
Pranlukast—CYSLTR1—brain—amyotrophic lateral sclerosis	0.0061	0.0267	CbGeAlD
Pranlukast—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.00162	0.0071	CbGeAlD
Pranlukast—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.00156	0.00683	CbGeAlD
Pranlukast—NFKB1—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.00116	0.0015	CbGpPWpGaD
Pranlukast—NFKB1—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.00116	0.0015	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00116	0.0015	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.00115	0.00149	CbGpPWpGaD
Pranlukast—IL5—Immune System—DCTN1—amyotrophic lateral sclerosis	0.00114	0.00147	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—APOE—amyotrophic lateral sclerosis	0.00112	0.00145	CbGpPWpGaD
Pranlukast—TNF—TWEAK Signaling Pathway—MMP9—amyotrophic lateral sclerosis	0.00112	0.00145	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—SOD1—amyotrophic lateral sclerosis	0.00111	0.00144	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—CASP3—amyotrophic lateral sclerosis	0.00111	0.00143	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PTGS2—amyotrophic lateral sclerosis	0.00111	0.00143	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.0011	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00109	0.00142	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00109	0.00141	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.00108	0.0014	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.00108	0.0014	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—CASP3—amyotrophic lateral sclerosis	0.00108	0.0014	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—CASP9—amyotrophic lateral sclerosis	0.00108	0.0014	CbGpPWpGaD
Pranlukast—NFKB1—LPA receptor mediated events—MMP9—amyotrophic lateral sclerosis	0.00105	0.00136	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—ERBB4—amyotrophic lateral sclerosis	0.00104	0.00135	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.00103	0.00134	CbGpPWpGaD
Pranlukast—TNF—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.00103	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.00102	0.00133	CbGpPWpGaD
Pranlukast—NFKB1—AGE/RAGE pathway—MMP9—amyotrophic lateral sclerosis	0.00102	0.00132	CbGpPWpGaD
Pranlukast—MUC2—Metabolism of proteins—IGF1—amyotrophic lateral sclerosis	0.000997	0.00129	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—ERBB4—amyotrophic lateral sclerosis	0.000997	0.00129	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	0.000996	0.00129	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CASP9—amyotrophic lateral sclerosis	0.000987	0.00128	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000951	0.00123	CbGpPWpGaD
Pranlukast—TNF—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.000932	0.00121	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—VEGFA—amyotrophic lateral sclerosis	0.000928	0.0012	CbGpPWpGaD
Pranlukast—CYSLTR1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.000927	0.0012	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—CASP9—amyotrophic lateral sclerosis	0.000925	0.0012	CbGpPWpGaD
Pranlukast—TNF—Caspase Cascade in Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000925	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000924	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000924	0.0012	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—ERBB4—amyotrophic lateral sclerosis	0.000923	0.0012	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000919	0.00119	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.000914	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—p75 NTR receptor-mediated signalling—CASP3—amyotrophic lateral sclerosis	0.000908	0.00118	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—SQSTM1—amyotrophic lateral sclerosis	0.000903	0.00117	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000902	0.00117	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.00089	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—SQSTM1—amyotrophic lateral sclerosis	0.000888	0.00115	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000882	0.00114	CbGpPWpGaD
Pranlukast—TNF—MicroRNAs in cardiomyocyte hypertrophy—IGF1—amyotrophic lateral sclerosis	0.000881	0.00114	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—IGF1—amyotrophic lateral sclerosis	0.000881	0.00114	CbGpPWpGaD
Pranlukast—IL5—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	0.000858	0.00111	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000848	0.0011	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000845	0.0011	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—CASP3—amyotrophic lateral sclerosis	0.000835	0.00108	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.000835	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—ATF1—amyotrophic lateral sclerosis	0.000833	0.00108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00083	0.00108	CbGpPWpGaD
Pranlukast—NFKB1—Corticotropin-releasing hormone—CASP3—amyotrophic lateral sclerosis	0.000828	0.00107	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000828	0.00107	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.000828	0.00107	CbGpPWpGaD
Pranlukast—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—amyotrophic lateral sclerosis	0.000821	0.00106	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000804	0.00104	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000804	0.00104	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CASP9—amyotrophic lateral sclerosis	0.000793	0.00103	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KIFAP3—amyotrophic lateral sclerosis	0.000784	0.00102	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—BDNF—amyotrophic lateral sclerosis	0.00078	0.00101	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000778	0.00101	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—DCTN1—amyotrophic lateral sclerosis	0.000762	0.000987	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—SOD1—amyotrophic lateral sclerosis	0.000759	0.000984	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—GSTP1—amyotrophic lateral sclerosis	0.000741	0.00096	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000728	0.000943	CbGpPWpGaD
Pranlukast—IL5—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000726	0.000941	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—PFN1—amyotrophic lateral sclerosis	0.000725	0.000939	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—CASP3—amyotrophic lateral sclerosis	0.000713	0.000923	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	0.000713	0.000923	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.000706	0.000915	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000704	0.000913	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	0.000704	0.000912	CbGpPWpGaD
Pranlukast—NFKB1—Oncostatin M Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000701	0.000908	CbGpPWpGaD
Pranlukast—NFKB1—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000692	0.000897	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000691	0.000896	CbGpPWpGaD
Pranlukast—NFKB1—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	0.000684	0.000887	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000683	0.000886	CbGpPWpGaD
Pranlukast—IL5—Immune System—ATF1—amyotrophic lateral sclerosis	0.000681	0.000883	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	0.000679	0.00088	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000678	0.000879	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—IGF1—amyotrophic lateral sclerosis	0.000677	0.000877	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	0.000672	0.000871	CbGpPWpGaD
Pranlukast—IL5—Immune System—CASP9—amyotrophic lateral sclerosis	0.000649	0.000841	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000647	0.000839	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000631	0.000818	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IGF1—amyotrophic lateral sclerosis	0.000621	0.000805	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000608	0.000789	CbGpPWpGaD
Pranlukast—TNF—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	0.000605	0.000784	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.0006	0.000777	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000592	0.000768	CbGpPWpGaD
Pranlukast—NFKB1—Glucocorticoid receptor regulatory network—TP53—amyotrophic lateral sclerosis	0.000582	0.000754	CbGpPWpGaD
Pranlukast—NFKB1—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	0.000579	0.00075	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000577	0.000748	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000571	0.00074	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000571	0.00074	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00056	0.000726	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000559	0.000724	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000557	0.000722	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—PTGS2—amyotrophic lateral sclerosis	0.000557	0.000722	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000556	0.000721	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000555	0.00072	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000543	0.000703	CbGpPWpGaD
Pranlukast—NFKB1—Apoptosis Modulation and Signaling—TP53—amyotrophic lateral sclerosis	0.000536	0.000694	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—TP53—amyotrophic lateral sclerosis	0.000528	0.000684	CbGpPWpGaD
Pranlukast—IL5—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000522	0.000677	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	0.000517	0.00067	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000512	0.000664	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.000511	0.000663	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000505	0.000654	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000504	0.000653	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000504	0.000653	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000497	0.000644	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000496	0.000643	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00049	0.000636	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	0.000488	0.000633	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00048	0.000622	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000476	0.000617	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ATF1—amyotrophic lateral sclerosis	0.000475	0.000616	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000473	0.000613	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.00047	0.000608	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—amyotrophic lateral sclerosis	0.000464	0.000601	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—DCTN1—amyotrophic lateral sclerosis	0.000462	0.000599	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000462	0.000598	CbGpPWpGaD
Pranlukast—IL5—Immune System—C3—amyotrophic lateral sclerosis	0.000461	0.000598	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000461	0.000597	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—amyotrophic lateral sclerosis	0.000457	0.000592	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	0.000457	0.000592	CbGpPWpGaD
Pranlukast—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000453	0.000587	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CASP9—amyotrophic lateral sclerosis	0.000453	0.000587	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.000449	0.000582	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000448	0.000581	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—amyotrophic lateral sclerosis	0.000442	0.000573	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.00044	0.000571	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000435	0.000564	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	0.000435	0.000563	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000419	0.000544	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—CASP3—amyotrophic lateral sclerosis	0.000416	0.000539	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.000413	0.000536	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.00041	0.000531	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000399	0.000517	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000392	0.000508	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	0.00039	0.000505	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	0.000387	0.000502	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	0.000379	0.000491	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	0.000372	0.000482	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000366	0.000475	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000362	0.00047	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000359	0.000465	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000357	0.000463	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.000352	0.000456	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.000351	0.000455	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	0.00035	0.000453	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000344	0.000446	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000337	0.000437	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000337	0.000437	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	0.000334	0.000433	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—amyotrophic lateral sclerosis	0.000334	0.000433	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	0.000331	0.00043	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.000328	0.000425	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.000327	0.000423	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000326	0.000422	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—C3—amyotrophic lateral sclerosis	0.000322	0.000417	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000321	0.000416	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.000316	0.00041	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000316	0.00041	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—C3—amyotrophic lateral sclerosis	0.000309	0.000401	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000307	0.000398	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—amyotrophic lateral sclerosis	0.000302	0.000392	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—amyotrophic lateral sclerosis	0.000302	0.000392	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000301	0.00039	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.000298	0.000387	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000298	0.000387	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000296	0.000384	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—SQSTM1—amyotrophic lateral sclerosis	0.000295	0.000382	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.000281	0.000364	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000278	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.000278	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ATF1—amyotrophic lateral sclerosis	0.000277	0.000359	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—amyotrophic lateral sclerosis	0.000266	0.000345	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CASP9—amyotrophic lateral sclerosis	0.000264	0.000342	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000258	0.000334	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	0.00025	0.000324	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00025	0.000323	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00025	0.000323	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000242	0.000314	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.000233	0.000302	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000229	0.000297	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—amyotrophic lateral sclerosis	0.000228	0.000296	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000228	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB4—amyotrophic lateral sclerosis	0.000226	0.000292	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.000225	0.000292	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000215	0.000278	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000214	0.000277	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000212	0.000275	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD40LG—amyotrophic lateral sclerosis	0.000212	0.000275	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000212	0.000275	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000204	0.000264	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000199	0.000259	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000199	0.000258	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000191	0.000247	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—C3—amyotrophic lateral sclerosis	0.000187	0.000243	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.000183	0.000237	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	0.00018	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000179	0.000232	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000177	0.000229	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.00017	0.000221	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000167	0.000216	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000165	0.000213	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000165	0.000213	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000165	0.000213	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—amyotrophic lateral sclerosis	0.000155	0.000201	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000151	0.000195	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.00015	0.000194	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000146	0.000189	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00014	0.000181	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	0.00014	0.000181	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.000137	0.000178	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000137	0.000177	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000132	0.000171	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000127	0.000164	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	0.000126	0.000164	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000121	0.000157	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.00012	0.000155	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000119	0.000154	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.000115	0.000149	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000113	0.000147	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000113	0.000146	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000108	0.000139	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000104	0.000134	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.46e-05	0.000123	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	9.32e-05	0.000121	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.02e-05	0.000117	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.32e-05	0.000108	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	8.13e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	7.18e-05	9.3e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.83e-05	8.86e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	6.78e-05	8.79e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.48e-05	8.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	6.09e-05	7.89e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.57e-05	7.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.12e-05	6.63e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	4.6e-05	5.96e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.21e-05	5.46e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.67e-05	4.76e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.38e-05	4.37e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.89e-05	3.74e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.78e-05	3.6e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.9e-05	2.47e-05	CbGpPWpGaD
